Semin intervent Radiol 2020; 37(05): 448-455
DOI: 10.1055/s-0040-1720950
Review Article

Treatment Options for Early-Stage Hepatocellular Carcinoma

Nora E. Tabori
1  Department of Radiology, Georgetown Medical School, Medstar Washington Hospital Center, Washington, District of Columbia
,
Gajan Sivananthan
1  Department of Radiology, Georgetown Medical School, Medstar Washington Hospital Center, Washington, District of Columbia
› Author Affiliations

Abstract

Patients with early stage hepatocellular carcinoma have good prognosis and are treated with curative intent. Although this cohort of patients is generally defined by limited tumor burden, good liver function, and preserved functional status, there remains utility in further stratification to optimize overall survival and limit post-operative morbidity and mortality. Transplant, resection, ablation, transarterial radioembolization, and transarterial chemoembolization, either as monotherapy or in combination, may play a crucial role in treating this cohort of patients depending on a multitude of factors. In this section, we review each treatment modality and provide general guidelines for patient selection.



Publication History

Publication Date:
11 December 2020 (online)

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA